Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, whether his Department has placed advance purchase orders for (a) next-generation universal coronavirus or (b) nasal-spray covid-19 vaccines.

The UK government has secured early access to 332 million vaccines doses through supply agreements with five separate vaccine developers. This includes agreements with:

• Pfizer/BioNTech for 135​ million doses
• University of Oxford/AstraZeneca for 100 million doses
• Moderna for 17 million doses
• Novavax for 60 million doses
• Janssen for 20 million doses.

We have not purchased any next-generation universal coronavirus or nasal-spray covid-19 vaccines; however, the Vaccine Taskforce keeps our portfolio and emerging vaccines under review.